Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to produce Fludrocortisone Acetate Tablets USP, 0.1 mg, according ... Read More
Zydus Lifesciences launches fight against prostate cancer with new FDA-approved drug enzalutamide
Zydus Lifesciences Limited has achieved a significant milestone in the pharmaceutical industry. The company recently received final approval from the United States Food and Drug ... Read More
Zydus and CSIR-CDRI launch collaborative research for new CKD-induced osteoporosis treatment
Zydus Lifesciences Ltd and CSIR-Central Drug Research Institute (CDRI) have joined forces to develop an innovative drug targeting osteoporosis induced by chronic kidney disease (CKD). ... Read More
Zydus Lifesciences wins FDA approval for Amantadine Capsules, secures 180-day exclusivity
Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has achieved a significant regulatory milestone by receiving final approval from the United States Food and ... Read More
Zydus Lifesciences to acquire 50% stake in Sterling Biotech from Perfect Day to expand into sustainable protein market
Zydus Lifesciences Limited, a major player in the global pharmaceutical industry, has entered a pivotal partnership by acquiring a 50% stake in Sterling Biotech Limited ... Read More
Game-changing MRI technology: Zynext Ventures bets big on Neuro42’s brain imaging
Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Neuro42 Inc., a US-based company specialising in advanced ... Read More
Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets
Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil ... Read More
Zydus Lifesciences gains tentative FDA approval for hypertension drug
Zydus Lifesciences Limited has achieved a significant milestone by receiving tentative approval from the United States Food and Drug Administration (USFDA) to market its combination ... Read More
Zydus Lifesciences wraps up enrollment for Phase II ALS trial of Usnoflast
Zydus Lifesciences, a renowned global pharmaceutical company, has achieved a significant milestone by completing the enrollment for the Phase II clinical trial of its novel ... Read More
Zydus Lifesciences reports Rs 19,547.4cr revenue from operations in FY24
Zydus Lifesciences Limited has released its financial results for the fourth quarter and the full fiscal year of 2024, showcasing impressive growth and operational success. ... Read More